SILICA CAPSULE 300MG (Pregabalin)
Pregabalin 300mg
Hard capsule · Prescription medication
Samik Pharmaceutical Co., Ltd.
MFDS item code 201906840 · Approved 2019.09.26
This product's status changed to Expired on 2024.09.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of epilepsy (partial seizures)
This medication is used for treating peripheral and central neuropathic pain in adults. It is also utilized as an adjunct in patients with epilepsy for partial seizures, with or without secondary generalized symptoms. Furthermore, it is effective for the treatment of fibromyalgia, primarily alleviating neuralgia and seizures, and helping to improve muscle pain symptoms. It is used for managing various neurological disorders and pain.
This medication is administered orally as pregabalin, with the total daily dose divided into 2 doses, regardless of food. Since this medication is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medication may be administered at an initial dose of 150mg per day. Based on each patient's response and tolerability, the dose may be increased to 300mg per day after 3 to 7 days. If necessary, it may then be increased at 7-day intervals up to a maximum of 600mg per day. 2) Central neuropathic pain Adults: This medication may be administered at an initial dose of 150mg per day. Based on each patient's response and tolerability, the dose may be increased to 300mg per day after 1 week. After an additional 1 week, it may be increased to the target daily dose of 600mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of treatment’) 2. Epilepsy Adults: This medication may be administered at an initial dose of 150mg per day. Based on each patient's response and tolerability, the dose may be increased to 300mg per day after 1 week. If necessary, it may then be increased at 7-day intervals up to a maximum of 600mg per day. 3. Fibromyalgia The recommended dose of this medication for fibromyalgia is 300mg∼450mg per day. The starting dose is 75mg twice daily (150mg per day), and based on efficacy and tolerability, it may be increased within 1 week to 150mg twice daily (300mg per day). For patients who do not experience sufficient benefit at a dose of 300mg per day, the dose may be increased within 1 week to 225mg twice daily (450mg per day). Clinical studies have also been conducted at a dose of 600mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450mg per day are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this medication is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medication is primarily excreted by the kidneys unchanged. Since the clearance of this medication is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *: For women, multiply the result obtained from the above calculation by 0.85. This medication is effectively removed from plasma by hemodialysis. (Approximately 50% within 4 hours) In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered immediately after every 4 hours of hemodialysis. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalina Dosage regimen Starting dose (mg/day) Maximum dose (mg/day) ≥60: Starting dose 150mg/day, maximum dose 600mg/day, BID or TID ≥30-<60: Starting dose 75mg/day, maximum dose 300mg/day, BID or TID ≥15-<30: Starting dose 25-50mg/day, maximum dose 150mg/day, QD or BID <15: Starting dose 25mg/day, maximum dose 75mg/day, QD Supplemental dose after hemodialysis: Starting dose 25mg, maximum dose 100mg, single dose TID = Total daily dose divided into 3 doses BID = Total daily dose divided into 2 doses QD = Once daily a: The total daily dose (mg/day) should be divided as specified in the dosage regimen. b: Supplemental dose refers to a dose administered as a single additional dose. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older adults (65 years of age and older) Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age: Administration is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 to 17 years: Administration is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behavior, so mood changes or depressive symptoms should be closely monitored during treatment. Individuals allergic to any components of this drug or those with genetic lactose intolerance should not take this medication. Diabetics may be affected in their blood sugar control due to weight gain, thus adjustments to their anti-diabetic medication may be necessary. If symptoms of angioedema, such as swelling of the face or around the mouth occur during treatment, discontinue use immediately and consult a physician. Elderly patients should be cautious, as dizziness or drowsiness may increase the risk of falls or injuries while taking this medication. Some patients may experience withdrawal symptoms like insomnia, headache, or anxiety when discontinuing this medication, so do not stop suddenly without consulting a doctor. There is a risk of misuse associated with this medication, so patients with a history of substance abuse should be particularly cautious while taking it. Patients with impaired kidney function should have their dose adjusted, and patients with severe heart disease should also use caution. Taking this drug with other substances that have central nervous system depressant effects or alcohol may increase the risk of drowsiness or respiratory depression, hence caution is advised. During early pregnancy, it is recommended to avoid this medication due to potential effects on the fetus, and women of childbearing age should use effective contraception. Breastfeeding women should consult a physician about discontinuing breast-feeding or the medication, as it can be transferred into breast milk. Before engaging in hazardous activities such as driving or operating machinery, check for dizziness or drowsiness caused by this medication. If severe skin reactions such as rashes, blisters, or fever occur during treatment, discontinue use immediately and inform healthcare professionals. In cases of overdose, symptoms such as confusion, drowsiness, or seizures may occur, necessitating immediate medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is also important to keep it in a cool place between 15 degrees and 30 degrees Celsius to maintain its efficacy.
Hard capsule with an upper reddish-brown and lower white color filled with white powder that is white or pale yellow.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pregabalin 300mg
Hard capsule · Prescription medication
Samik Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.